These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 33282960)
1. Quantitative Analysis of Retinal Microvascular Perfusion and Novel Biomarkers of the Treatment Response in Diabetic Macular Edema. Park YG; Park YH J Diabetes Res; 2020; 2020():2132037. PubMed ID: 33282960 [TBL] [Abstract][Full Text] [Related]
2. Qualitative and Quantitative Assessment of Vascular Changes in Diabetic Macular Edema after Dexamethasone Implant Using Optical Coherence Tomography Angiography. Toto L; D'Aloisio R; Di Nicola M; Di Martino G; Di Staso S; Ciancaglini M; Tognetto D; Mastropasqua L Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574436 [TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505 [TBL] [Abstract][Full Text] [Related]
4. Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema. Cheong KX; Lee SY; Ang M; Teo KYC Turk J Ophthalmol; 2020 Dec; 50(6):343-350. PubMed ID: 33389934 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of optical coherence tomography angiography in management of diabetic macular edema. Basiony AI; Mohamed Gad Marey H; Ezzat Abdel Fattah AM; Aly Zaky M BMC Ophthalmol; 2024 Oct; 24(1):429. PubMed ID: 39354390 [TBL] [Abstract][Full Text] [Related]
6. Application of optical coherence tomography angiography in the assessment of diabetic macular edema staging and laser photocoagulation efficacy. Fu WN; Du Y; Gong ZY Photodiagnosis Photodyn Ther; 2024 Apr; 46():104055. PubMed ID: 38508440 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab and dexamethasone implant for treatment of chronic diabetic macular edema. Güler E; Totan Y; Betül Güragaç F Cutan Ocul Toxicol; 2017 Jun; 36(2):180-184. PubMed ID: 28366074 [TBL] [Abstract][Full Text] [Related]
8. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema. Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223 [TBL] [Abstract][Full Text] [Related]
9. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids. Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333 [TBL] [Abstract][Full Text] [Related]
10. Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment. Moon BG; Um T; Lee J; Yoon YH Ophthalmol Retina; 2018 Mar; 2(3):235-243. PubMed ID: 31047592 [TBL] [Abstract][Full Text] [Related]
11. OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion. Choi KE; Yun C; Cha J; Kim SW Sci Rep; 2019 Oct; 9(1):14153. PubMed ID: 31578437 [TBL] [Abstract][Full Text] [Related]
12. Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants. Rübsam A; Wernecke L; Rau S; Pohlmann D; Müller B; Zeitz O; Joussen AM J Diabetes Res; 2021; 2021():8820216. PubMed ID: 33937416 [TBL] [Abstract][Full Text] [Related]
13. Comparison of retinal layer thickness and microvasculature changes in patients with diabetic retinopathy treated with intravitreous bevacizumab vs panretinal photocoagulation. Lee MW; Baek SK; Lee KH; Lee SC; Kim JY; Lee YH Sci Rep; 2022 Jan; 12(1):1570. PubMed ID: 35091585 [TBL] [Abstract][Full Text] [Related]
14. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion. Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457 [TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography angiography analysis of microvascular abnormalities and vessel density in treatment-naïve eyes with diabetic macular edema. Braham IZ; Kaouel H; Boukari M; Ammous I; Errais K; Boussen IM; Zhioua R BMC Ophthalmol; 2022 Nov; 22(1):418. PubMed ID: 36329416 [TBL] [Abstract][Full Text] [Related]
16. The additive effect of intravitreal dexamethasone combined with bevacizumab in refractory diabetic macular edema. Karimi S; Karrabi N; Hassanpour K; Amirabadi A; Daneshvar K; Nouri H; Abtahi SH J Fr Ophtalmol; 2023 Nov; 46(9):1019-1029. PubMed ID: 37481454 [TBL] [Abstract][Full Text] [Related]
17. Macular and peripapillary microvasculature after dexamethasone injection in diabetic macular edema. Ozcalıskan S; Pehlıvanoglu S; Huseyınhan Z; Alagoz C; Erdogan G; Artunay O Eur J Ophthalmol; 2022 Sep; 32(5):2752-2759. PubMed ID: 34766511 [TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema. He Y; Ren XJ; Hu BJ; Lam WC; Li XR BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048 [TBL] [Abstract][Full Text] [Related]
19. RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study. Winegarner A; Wakabayashi T; Hara-Ueno C; Sato T; Busch C; Fukushima Y; Sayanagi K; Nishida K; Sakaguchi H; Nishida K Retina; 2018 Oct; 38(10):2067-2072. PubMed ID: 28902097 [TBL] [Abstract][Full Text] [Related]
20. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM; BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]